Septic Arthritis

• Bacterial adherence and synovial colonization: Pathogenic organisms express adhesion molecules and virulence factors that promote binding to synovial epithelial cells and extracellular matrix components. Staphylococcus aureus, the most common cause, produces multiple adhesins including collagen-binding proteins and fibrinogen-binding clumping factors that facilitate initial attachment and biofilm formation. Once established, bacteria multiply rapidly in the nutrient-rich synovial fluid, which lacks opsonizing antibodies and complement early in infection.

• Inflammatory cascade and cytokine-mediated joint destruction: Bacterial lipopolysaccharides (LPS) and peptidoglycans trigger toll-like receptor (TLR) signaling on resident macrophages and synovial fibroblasts, activating NF-κB and MAPK pathways. This stimulates massive production of pro-inflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and interleukin-8 (IL-8). These cytokines induce cyclooxygenase-2 (COX-2) and nitric oxide synthase (NOS), generating prostaglandins and nitric oxide that amplify inflammation. Simultaneously, these mediators upregulate matrix metalloproteinases (MMPs), particularly MMP-1 and MMP-9, which degrade collagen and proteoglycan in articular cartilage, driving progressive structural damage.

• Neutrophil infiltration and enzymatic destruction: The inflammatory milieu recruits massive numbers of polymorphonuclear leukocytes (PMNs) through chemotactic gradients, with PMN counts in infected synovial fluid reaching 50,000-300,000 cells/μL. PMNs attempt bacterial killing through phagocytosis and release of granular contents including elastase, collagenase, and lactoferrin. However, this antimicrobial response paradoxically amplifies tissue destruction through "collateral damage"—PMN proteases degrade type II collagen, aggrecan, and other cartilage matrix components. The synovial fluid becomes increasingly viscous and purulent, elevating intra-articular pressure and further compromising cartilage nutrition through diffusion.

• Cartilage ischemia and irreversible damage: Rising intra-articular pressure compresses the synovial vasculature, reducing blood flow to cartilage and shifting cartilage metabolism toward anaerobic respiration. Within 24-48 hours of untreated infection, chondrocytes undergo apoptosis due to combined effects of direct bacterial toxins (particularly S. aureus α-toxin and Panton-Valentine leukocidin), cytokine-induced cell death, acidosis, and nutrient deprivation. Unlike most tissues that can regenerate, articular cartilage has extremely limited reparative capacity, explaining why delays in treatment directly correlate with permanent joint damage. Bacteria may also directly invade and damage the glycosaminoglycan matrix and collagen scaffold, with some organisms (particularly Group B Streptococcus) producing hyaluronidase and other tissue-degrading enzymes.

• Biofilm formation and antimicrobial resistance: Within hours to days, some bacteria, particularly S. aureus and Pseudomonas aeruginosa, form biofilms—organized multicellular communities encased in polysaccharide exopolymeric substance. Biofilms reduce bacterial susceptibility to antibiotics by 100-1000 fold through multiple mechanisms: reduced antibiotic penetration, altered bacterial physiology (slow-growing or stationary-phase organisms), and expression of antibiotic resistance genes. This explains why joint drainage is critical—antibiotics alone cannot penetrate biofilm-protected bacteria, and prolonged infection despite appropriate antibiotics should raise suspicion for inadequate source control.

• Staphylococcus aureus: Accounts for 40-50% of all septic arthritis cases in both native and prosthetic joints. Methicillin-resistant S. aureus (MRSA) prevalence ranges from 20-40% depending on geographic location and healthcare exposure. Both toxin production (particularly Panton-Valentine leukocidin) and enhanced biofilm formation contribute to tissue damage and treatment resistance. MRSA septic arthritis carries worse prognosis and requires vancomycin or other anti-MRSA agents rather than beta-lactams.

• Streptococcal species: Streptococcus pyogenes (Group A Streptococcus) causes acute, rapidly progressive arthritis particularly in children and may follow minor skin trauma. Group B Streptococcus predominates in neonates (typically acquired intrapartum from maternal flora) and produces tissue-degrading enzymes. Streptococcus agalactiae infections in older adults (>50 years) often correlate with underlying bacteremia from other sources.

• Gram-negative organisms: Neisseria gonorrhoeae remains an important cause in sexually active adults, classically presenting as migratory polyarthralgia followed by purulent monoarthritis; it should be strongly suspected in young patients with septic arthritis and genital symptoms or exposure. Pseudomonas aeruginosa predominates in intravenous drug users (particularly those with joint injections) and healthcare-associated infections. Haemophilus influenzae (type b) incidence has dramatically declined with Hib vaccination but remains relevant in unvaccinated or immunocompromised patients.

• Fungal and mycobacterial causes: Occur almost exclusively in immunocompromised hosts (HIV/AIDS, solid organ transplant, immunosuppressive therapies). Candida albicans, Cryptococcus neoformans, and Histoplasma capsulatum can seed joints hematogenously during disseminated infection. Mycobacterial arthritis (particularly Mycobacterium tuberculosis) typically presents subacutely with minimal systemic symptoms and requires prolonged multi-drug therapy.

• Age extremes: Neonates (<3 months) have immature immune systems and transient bacteremia from birth canal flora; septic arthritis in neonates may be subtle with fever being absent in 20-30%. Elderly patients (>65 years) have multiple comorbidities and may present atypically with muted inflammatory responses and normal temperature.

• Immunosuppression: Patients on TNF-α inhibitors, other immunosuppressive agents, or those with HIV/AIDS (especially CD4 <50) are susceptible to opportunistic organisms including fungi and atypical mycobacteria. Rheumatoid arthritis patients on biologic DMARDs have increased risk of septic arthritis, particularly with S. aureus.

• Joint characteristics: Pre-existing rheumatologic disease (rheumatoid arthritis, systemic lupus erythematosus, seronegative spondyloarthropathies) substantially increases risk through multiple mechanisms: altered joint anatomy, immunologic dysfunction, and potential for recurrent bacteremia. Prosthetic joints carry lifetime risk of infection (0.5-2% depending on time post-implantation and type of prosthesis). Previous joint injection (therapeutic or illicit) creates direct inoculation risk; intravenous drug use with joint injection is particularly high-risk.

• Concurrent bacteremia or recent infection: Hematologic malignancies and neutropenia create profound immunosuppression allowing hematogenous seeding. Recent skin/soft tissue infection, endocarditis, or urinary tract infection can seed joints during bacteremic episodes. Invasive procedures including arthrocentesis, arthroplasty, or arthroscopy carry procedural risk if performed in setting of bacteremia or with inadequate sterile technique.

• Specific pathogen associations: Gonorrhea risk correlates with new sexual partners and lack of barrier contraception. Tuberculous arthritis risk increases with recent TB exposure, immigration from endemic areas, or immunosuppression. Fungal arthritis risk parallels degree of immunosuppression (CD4 count <200 in HIV, prolonged corticosteroid use, or post-transplant state).

• Fever: Present in 80-90% of cases but may be absent or muted in neonates, elderly patients, or those on immunosuppressive therapy. Fever typically develops concurrent with or shortly after joint symptoms, representing the systemic inflammatory response to bacterial invasion. High spiking fevers suggest aggressive pathogens (S. aureus, Group B Strep) while low-grade fever may indicate fastidious organisms (N. gonorrhoeae, mycobacteria).

• Acute joint pain and functional limitation: Pain is often severe and disproportionate to physical findings, driven by intra-articular pressure elevation and inflammatory mediators. Pain is typically constant (not intermittent like mechanical arthritis) and significantly worse with any motion. Patients characteristically hold the joint in the position of maximal comfort (usually slight flexion) to minimize intra-articular pressure and pain.

• Joint swelling: Visible effusion develops within hours as synovial edema and fluid accumulation increase intra-articular volume. In superficial joints (knee, ankle, shoulder), swelling is visibly apparent. In deep joints (hip), swelling may be clinical silent externally but causes severe pain, particularly with internal rotation and adduction (flexion-adduction-internal rotation position indicates hip effusion).

• Joint warmth and erythema: Overlying skin erythema and warmth indicate superficial spread of inflammation; their presence correlates with more severe infection but their absence does not exclude septic arthritis. Warmth is best appreciated by comparing the infected joint to the contralateral side using the dorsum of the examiner's hand.

• Refusal to bear weight or use extremity: In lower extremity septic arthritis (knee, ankle, hip), patients refuse weight-bearing due to severe pain. In upper extremities, patients maintain the affected arm immobile against the body. Young children may present with refusal to move the extremity and pseudoparalysis despite intact neuromuscular function.

Important clinical variants and atypical presentations

• Hip septic arthritis in infants and young children: Hip involvement may be initially subtle because the hip is deep and swelling is not visibly apparent. Clues include pain with internal rotation, holding the hip in flexion-abduction-external rotation, irritability during diaper changes, or refusal to stand/walk. Delay in diagnosis is common because clinical suspicion may be low in absence of obvious swelling.

• Gonococcal arthritis: Often presents as migratory polyarthralgia/polyarthritis (knees, wrists, ankles, elbows) in the initial phase, followed by progression to purulent monoarthritis in 50-70% of cases. A distinctive petechial or pustular rash on extremities (particularly palms and soles) occurs in 40% of cases. Genital symptoms may be subtle or absent, particularly in females with cervicitis or males with urethritis. Disseminated gonococcal infection (DGI) represents a spectrum from migratory arthralgia to septic arthritis.

• Polyarticular septic arthritis: Accounts for 10-15% of cases and indicates more severe systemic infection, often with underlying immunosuppression. Multiple joints (typically 2-4) are affected simultaneously or in rapid succession. Associated endocarditis, prosthetic valve infection, or osteomyelitis should be excluded.

• Tuberculosis and fungal arthritis: Present subacutely (weeks to months) with low-grade fever and insidious joint swelling. Constitutional symptoms (weight loss, night sweats, fatigue) are prominent. Without high clinical suspicion, diagnosis is often delayed by months.

• Atypical presentations in high-risk groups: Neonates may present with irritability, poor feeding, or unexplained fever without localizing joint symptoms. Elderly patients may have minimal fever and present primarily with functional decline or inability to ambulate. Patients on immunosuppressive therapy may have blunted fever response but surprisingly severe joint involvement.

Clinical suspicion triggers

• Acute monoarthritis with fever in any patient
• Any acute polyarthritis with fever, particularly with underlying rheumatologic disease
• Recent joint injection or procedure with fever/joint symptoms
• Persistent joint pain/swelling despite apparent cellulitis treatment
• New joint swelling in patient with known bacteremia source (endocarditis, IV line infection)

• Cell count and differential: White blood cell count typically ranges from 50,000-200,000 cells/μL (often >100,000), with >90% polymorphonuclear leukocytes. The cutoff of 50,000 cells/μL has ~75% sensitivity and ~98% specificity for septic arthritis; however, early infection (<24 hours) or infections in immunocompromised patients may have lower counts. Conversely, inflammatory arthritis may occasionally exceed 50,000 cells/μL. Red blood cell count is typically low (unless traumatic arthrocentesis).

• Glucose and protein: Synovial fluid glucose is typically <40 mg/dL in bacterial septic arthritis and usually significantly lower than serum glucose (ratio <0.5), though hyperglycemic patients may have higher synovial glucose levels. Protein is elevated (>3 g/dL) from inflammatory exudation. N. gonorrhoeae may present with lower synovial fluid glucose but not always.

• Gram stain and culture: Gram stain is positive in 50-70% of cases and provides rapid organism identification, directly guiding antibiotic selection. Culture is the diagnostic gold standard (sensitivity 80-95% if obtained before antibiotics) and should be obtained in all cases with sufficient sample volume. Culture-negative septic arthritis occurs in 5-20% of cases and may reflect prior antibiotic administration, fastidious organisms, or low bacterial burden.

• Nucleic acid amplification testing (NAAT) and PCR: Increasingly used for rapid organism identification (within 1-4 hours) and can identify fastidious organisms (N. gonorrhoeae, Chlamydia trachomatis, mycobacteria) not readily cultured. Broad-range bacterial 16S rRNA PCR can identify organism in culture-negative cases. Implementation varies by institution.

• Fever >38.5°C
• Inability to bear weight
• Serum WBC >12,000 cells/μL
• Synovial fluid WBC >50,000 cells/μL

Laboratory studies beyond synovial fluid

• Blood cultures: Obtained in all patients prior to antibiotics; positive in 50-60% of bacteremic patients and confirm organisms when joint culture is negative or delayed.
• Complete blood count (CBC): Elevated WBC with left shift is common but not sensitive. Thrombocytopenia or thrombocytosis may reflect severity.
• Inflammatory markers: Erythrocyte sedimentation rate (ESR) elevated in >95% of cases, C-reactive

Immediate priorities (before antibiotics)

• Arthrocentesis first: aspirate the joint (and draw blood cultures) before the first antibiotic dose whenever the patient is hemodynamically stable — a single dose can sterilize synovial fluid and forfeit the organism. If the patient is septic, treat shock (IV crystalloid, cultures, empiric antibiotics) and aspirate as soon as feasible; never delay antibiotics in a decompensating patient for imaging.

Empiric antimicrobial therapy

• Anti-MRSA glycopeptide: vancomycin IV is the default empiric backbone because S. aureus predominates; per the 2020 IDSA/ASHP/PIDS/SIDP consensus, dose to a 24-hour AUC/MIC of 400–600, not to a AUC/MIC 400-600 per the 2020 IDSA/ASHP consensus. Daptomycin or linezolid are alternatives for intolerance or vancomycin failure (IDSA MRSA guideline).
• Add gram-negative coverage when Gram stain shows gram-negative rods or the host is elderly, immunocompromised, or an injection drug user: an antipseudomonal beta-lactam (cefepime or piperacillin-tazobactam).
• Suspected disseminated gonococcal infection: third-generation cephalosporin — ceftriaxone 1 g IV/IM q24h — with doxycycline if chlamydia is not excluded, per the CDC STI Treatment Guidelines. Gonococcal arthritis usually resolves without formal surgical drainage.
• De-escalate to a narrow agent once culture and susceptibilities return (e.g., nafcillin/cefazolin for MSSA, penicillin for streptococci). Total course is typically several weeks, largely IV, individualized by organism and source control.

Definitive management — source control

• Joint drainage is mandatory: antibiotics cannot penetrate purulent debris or biofilm. Options are serial large-bore needle aspiration, arthroscopic lavage, or open arthrotomy.
• Urgent open surgical drainage for the hip (especially in children), the shoulder, loculated or radiographically eroded joints, and any joint failing to improve after repeat aspiration.
• Prosthetic joints: per the IDSA prosthetic joint infection guideline, early post-implant or acute hematogenous infection with a stable implant may be managed by debridement with implant retention plus rifampin-containing therapy for staphylococci; chronic infection requires one- or two-stage exchange.

Contraindicated/avoid

• Intra-articular corticosteroids and reliance on NSAIDs alone.
• Needle passage through overlying cellulitis (seeds a sterile joint).
• Empiric antibiotics without attempted aspiration in a stable patient.

Joint and bone complications

• Irreversible cartilage destruction and secondary osteoarthritis: neutrophil proteases and MMPs degrade type II collagen within days; signaled by persistent pain and stiffness after infection clears, with joint-space narrowing on follow-up radiographs.
• Fibrous or bony ankylosis and chronic contracture: granulation tissue bridges denuded cartilage; the patient regains no arc of motion despite microbiologic cure.
• Contiguous osteomyelitis: bacteria cross into subchondral bone, particularly where the metaphysis is intracapsular (proximal femur, radial neck, proximal humerus); suspect with fever and elevated inflammatory markers that fail to fall after adequate drainage — obtain MRI.
• Avascular necrosis of the femoral head and physeal (growth plate) injury: rising intracapsular pressure tamponades the retinacular vessels; in children this produces limb-length discrepancy, coxa magna, or deformity years later. Untreated hip septic arthritis in a child is a surgical emergency for this reason.

Systemic complications

• Bacteremia, sepsis, and septic shock: hypotension, lactate elevation, and organ dysfunction — an emergency requiring resuscitation per Surviving Sepsis principles alongside drainage.
• Infective endocarditis and metastatic abscess: S. aureus bacteremia seeds valves; a new murmur, embolic phenomena, or persistently positive blood cultures on appropriate therapy mandates echocardiography.
• Polyarticular involvement: implies ongoing bacteremia and carries markedly higher mortality.

Treatment-related complications

• Vancomycin-associated acute kidney injury: risk rises with higher exposures and concomitant piperacillin-tazobactam; signaled by a rising creatinine — the rationale for AUC-guided rather than trough-guided dosing (2020 IDSA/ASHP consensus).
• Vancomycin infusion reaction (red man syndrome): histamine release from rapid infusion; flushing of face and torso, resolves with slower infusion and antihistamine — not a true IgE allergy.
• Linezolid myelosuppression and serotonin syndrome; daptomycin myopathy with rising CK.
• ***C. difficile* colitis** after prolonged broad-spectrum therapy; new watery diarrhea and leukocytosis.
• Long-term IV catheter complications: line infection and upper-extremity DVT.
• Rifampin (used with retained hardware): hepatotoxicity, orange body fluids, and potent CYP450 induction reducing warfarin and contraceptive efficacy.

• Acute monoarthritis plus fever is septic arthritis until proven otherwise, and the single best next step is arthrocentesis with cell count, Gram stain, culture, and crystal analysis — before antibiotics, before MRI, before starting steroids. Imaging never precedes aspiration in a stable patient.
• **The knee is the most commonly involved joint and S. aureus is the most common organism overall** across native joints and most risk groups; empiric coverage must therefore include MRSA (vancomycin, dosed to AUC/MIC 400–600 per the 2020 IDSA/ASHP consensus).
• Neisseria gonorrhoeae is the classic cause in a young, sexually active patient: the triad of migratory polyarthralgia, tenosynovitis, and pustular/petechial rash on distal extremities. Synovial cultures are often negative — send NAAT of urethral, cervical, pharyngeal, and rectal sites, and treat with ceftriaxone per CDC STI guidelines.
• The commonest distractor: "crystals were seen, so it isn't infection." Gout or pseudogout can coexist with septic arthritis. Positive Gram stain or culture overrides the crystal finding; treat the infection.
• Antibiotics alone are never sufficient — drainage is mandatory because biofilm and purulent debris shield organisms. Septic arthritis of the hip, particularly in a child, requires urgent open surgical drainage to prevent avascular necrosis and physeal damage.
• Kocher criteria distinguish septic arthritis from transient synovitis in a limping child (fever >38.5°C, non-weight-bearing, WBC >12,000/μL, elevated ESR); transient synovitis is the classic wrong answer in an afebrile, well-appearing child who bears weight.
• Plain radiographs are normal early and cannot exclude the diagnosis; their role is baseline assessment and detection of contiguous osteomyelitis or a foreign body. MRI is for the deep joint (hip, sacroiliac, sternoclavicular) or suspected osteomyelitis/abscess.
• Prosthetic joint infection is a different disease: lower synovial WBC thresholds apply, and management follows the IDSA PJI guideline (debridement with retention plus rifampin for staphylococci if acute and stable, versus staged exchange).